KINJAL PATEL: Open Payments
NPI 1437558624 · NEW BRUNSWICK, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$167 in 10 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $84 · 2025 $167
Food & beverage: $167
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| CARDIVA MEDICAL, INC. | 2 | $32 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
| Novo Nordisk Inc | 1 | $15 |
Products named: JARDIANCE, BREZTRI, CARDIVA VASCADE MVP VVCS 6-12F, NEXLETOL, Assure WCD, Wegovy.
Industry payments across NJ — which companies pay providers there.
